Skip to main content
Move the World.
coronavirus news

Lead image courtesy of the Centers for Disease Control and Prevention.

The coronavirus crisis is unique. Addressing it will require new ideas, new perspectives, and new voices. That's our mission at Freethink.

This week, we're highlighting some of the most interesting perspectives and opinions about the fight against COVID-19.

Here are our must reads for this week.

1. Why the Coronavirus Is So Confusing

We're now four months into the COVID-19 pandemic, and the world still has far more questions about the coronavirus than answers. This piece from the Atlantic's Ed Yong breaks down the eight factors contributing to that confusion and how you can keep it straight.

2. What You Need to Know About the COVID-19 Vaccine

Right now, our best hope for ending the COVID-19 outbreak is the development and widespread distribution of a coronavirus vaccine. This week, Bill Gates published a detailed account of the race to reach that vaccine — and the obstacles still standing between us and it.

3. Let's Bury the Hatchet!

Coronavirus lockdowns have left a lot of people with extra time on their hands — and according to this piece by Abby Ellin in the New York Times, many are using it to repair old relationships and reconnect with people from their past.

4. Infect Volunteers With COVID-19? A Proposal Lays Bare a Minefield of Issues

In March, a trio of researchers from the U.S. and the U.K. published an article suggesting that scientists deliberately infect volunteers with the coronavirus as a way of testing potential vaccines. This STAT article by Helen Branswell weighs the pros and cons of the controversial proposal.

Did we leave something off this list? We want to hear about what you're reading and any interesting ideas you'd like us to cover. Drop us a line at [email protected].

Up Next

If you want to understand a problem, talk to the people working on solutions. Join us as we meet the people and explore the ideas on the frontlines of an unprecedented global response.

Public Health
How to Make 100 Million Doses of Coronavirus Vaccine in a Year
coronavirus vaccine
Public Health
How to Make 100 Million Doses of Coronavirus Vaccine in a Year
Creating a new vaccine is slow and expensive. One biotech firm thinks a “plug-and-play” vaccine could change that.

Creating a new vaccine is slow and expensive. One biotech firm thinks a “plug-and-play” vaccine could change that.

Public Health
Bill Gates Is Spending Billions to Produce 7 Coronavirus Vaccines
coronavirus vaccines
Public Health
Bill Gates Is Spending Billions to Produce 7 Coronavirus Vaccines
The Gates Foundation is building factories to manufacture seven promising coronavirus vaccines to prepare for mass production if any prove effective.

The Gates Foundation is building factories to manufacture seven promising coronavirus vaccines to prepare for mass production if any prove effective.

Public Health
Major Drugmakers Team Up on Potential Coronavirus Vaccine
Potential Coronavirus Vaccine
Public Health
Major Drugmakers Team Up on Potential Coronavirus Vaccine
Major vaccine developers GlaxoSmithKline and Sanofi are collaborating on a potential coronavirus vaccine to help end the COVID-19 pandemic.

Major vaccine developers GlaxoSmithKline and Sanofi are collaborating on a potential coronavirus vaccine to help end the COVID-19 pandemic.

Public Health
Big Tobacco Announces "Breakthrough" in Plant-Based Coronavirus Vaccine
Plant-Based Coronavirus Vaccine
Public Health
Big Tobacco Announces "Breakthrough" in Plant-Based Coronavirus Vaccine
A plant-based coronavirus vaccine developed by a subsidiary of British American Tobacco is now undergoing pre-clinical testing.

A plant-based coronavirus vaccine developed by a subsidiary of British American Tobacco is now undergoing pre-clinical testing.

Coronavirus
Researchers Found Tiny COVID-19 Antibodies In An Alpaca
nanobodies
Coronavirus
Researchers Found Tiny COVID-19 Antibodies In An Alpaca
Inside an alpaca’s blood, researchers have found tiny antibodies — nanobodies — that may lead to future antiviral medications.

Inside an alpaca’s blood, researchers have found tiny antibodies — nanobodies — that may lead to future antiviral medications.

Coronavirus
Updated Coronavirus Vaccine List: Where We Stand Today
Coronavirus Vaccine List
Coronavirus
Updated Coronavirus Vaccine List: Where We Stand Today
A regularly updated coronavirus vaccine list highlighting the candidates closest to receiving approval from regulators.

A regularly updated coronavirus vaccine list highlighting the candidates closest to receiving approval from regulators.

Coronavirus
COVID-19 Tests That Are Fast, Cheap, and Less Accurate May Be Key
covid-19 tests
Coronavirus
COVID-19 Tests That Are Fast, Cheap, and Less Accurate May Be Key
Fast, cheap, DIY COVID-19 tests could dramatically increase the amount of testing done. And some experts think the trade off in accuracy would be worth it.

Fast, cheap, DIY COVID-19 tests could dramatically increase the amount of testing done. And some experts think the trade off in accuracy would be worth it.

Public Health
Chinese Coronavirus Vaccine Advances to Next Trial Phase
Chinese Coronavirus Vaccine
Public Health
Chinese Coronavirus Vaccine Advances to Next Trial Phase
CanSino Bio’s Ad5-nCoV was the first Chinese coronavirus vaccine to be tested in humans. Now it’s the first in the world to enter Phase II trials.

CanSino Bio’s Ad5-nCoV was the first Chinese coronavirus vaccine to be tested in humans. Now it’s the first in the world to enter Phase II trials.

Public Health
New Coronavirus Test Could Check One Million People Daily
Coronavirus Test
Public Health
New Coronavirus Test Could Check One Million People Daily
BillionToOne has announced the creation of a coronavirus test it says would allow the U.S. to check more than one million people for COVID-19 daily.

BillionToOne has announced the creation of a coronavirus test it says would allow the U.S. to check more than one million people for COVID-19 daily.